CSPI Targets OTC Male Enhancement Products With Enzyte FTC Letter
This article was originally published in The Tan Sheet
Executive Summary
The Federal Trade Commission should immediately enjoin national television ads for Berkeley Premium Nutraceuticals' herbal supplement Enzyte, according to the Center for Science in the Public Interest
You may also be interested in...
AMA Cites Enzyte Marketer In Call For Stronger Supplement Ad Regulation
The American Medical Association is pushing for stronger regulation of herbal supplement advertising based on the concern that some ads looks like promotions for Rx drugs
AMA Cites Enzyte Marketer In Call For Stronger Supplement Ad Regulation
The American Medical Association is pushing for stronger regulation of herbal supplement advertising based on the concern that some ads looks like promotions for Rx drugs
AMA Cites Enzyte Marketer In Call For Stronger Supplement Ad Regulation
The American Medical Association is pushing for stronger regulation of herbal supplement advertising based on the concern that some ads looks like promotions for Rx drugs